MoonLake Immunotherapeutics (MLTX) Earnings Date, Estimates & Call Transcripts

$41.02
-1.17 (-2.77%)
(As of 04/22/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 10Estimated
Actual EPS
(Feb. 29)
-$0.12 Beat By $0.11
Consensus EPS
(Feb. 29)
-$0.23
Skip Charts & View Estimated and Actual Earnings Data

MLTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MLTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

MoonLake Immunotherapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.30)($0.20)($0.25)
Q2 20242($0.42)($0.22)($0.32)
Q3 20242($0.55)($0.24)($0.40)
Q4 20242($0.65)($0.27)($0.46)
FY 20248($1.92)($0.93)($1.43)
Q1 20251($0.75)($0.75)($0.75)
Q2 20251($0.79)($0.79)($0.79)
Q3 20251($0.73)($0.73)($0.73)
Q4 20251($0.58)($0.58)($0.58)
FY 20254($2.85)($2.85)($2.85)

MLTX Earnings Date and Information

MoonLake Immunotherapeutics last announced its quarterly earnings results on February 29th, 2024. The reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.11. MoonLake Immunotherapeutics has generated ($0.76) earnings per share over the last year (($0.76) diluted earnings per share). Earnings for MoonLake Immunotherapeutics are expected to decrease in the coming year, from ($1.11) to ($1.56) per share. MoonLake Immunotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off prior year's report dates.

MoonLake Immunotherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/10/2024
Estimated)
------- 
2/29/2024Q4 2023($0.23)($0.12)+$0.11($0.12)--
11/14/2023Q3 2023($0.23)($0.18)+$0.05($0.18)--
8/10/2023Q2 2023($0.27)($0.23)+$0.04($0.23)--  
5/12/2023Q1 2023($0.28)($0.23)+$0.05($0.23)--
3/20/2023Q4 2022($0.33)($0.31)+$0.02($0.31)--
11/14/2022Q3 2022($0.32)($0.27)+$0.05($0.27)--
8/12/2022Q2 2022-($0.34)($0.34)($0.34)--
5/16/2022Q1 2022-($0.18)($0.18)($0.18)--

MoonLake Immunotherapeutics Earnings - Frequently Asked Questions

When is MoonLake Immunotherapeutics's earnings date?

MoonLake Immunotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 10th, 2024 based off last year's report dates. Learn more on MLTX's earnings history.

Did MoonLake Immunotherapeutics beat their earnings estimates last quarter?

In the previous quarter, MoonLake Immunotherapeutics (NASDAQ:MLTX) reported ($0.12) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.11. Learn more on analysts' earnings estimate vs. MLTX's actual earnings.

How much profit does MoonLake Immunotherapeutics generate each year?

MoonLake Immunotherapeutics (NASDAQ:MLTX) has a recorded net income of -$36.01 million. MLTX has generated -$0.76 earnings per share over the last four quarters.

What is MoonLake Immunotherapeutics's EPS forecast for next year?

MoonLake Immunotherapeutics's earnings are expected to decrease from ($1.11) per share to ($1.56) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MLTX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners